Psychedelics and Cognitive Flexibility
Single Psychedelic Dose Enhances Brain Flexibility for Weeks: Breakthrough Mouse Study Maps Lasting Cognitive Benefits
In groundbreaking peer-reviewed research published in Psychedelics, scientists have discovered that a single dose of a psychedelic compound can enhance cognitive flexibility in mice for at least three weeks after administration. This pioneering study by Elizabeth J. Brouns, Tyler G. Ekins, and Omar J. Ahmed from the University of Michigan offers the first evidence that psychedelics' cognitive benefits persist long after the drug has left the system, opening new therapeutic avenues for conditions marked by rigid thinking patterns.
David Rubinsztein Interview
Autophagy Pioneer Reveals How Cellular "Recycling" Could Transform Treatment of Alzheimer's and Parkinson's
Exclusive Genomic Press interview with Cambridge scientist who discovered the brain's critical self-cleaning mechanism offers unprecedented insights into combating neurodegenerative diseases and the future of dementia therapy...
Yicheng Zhang Early infant white matter tract microstructure
Brain Wiring in 3-Month-Old Infants Predicts Future Emotional Development
New research reveals that the microscopic structure of white matter connections in infant brains can predict how their emotional responses will develop over the coming months, offering potential early markers for identifying children at risk for future emotional and behavioral disorders. The groundbreaking study, conducted by researchers at the University of Pittsburgh, demonstrates how advanced brain imaging can illuminate the biological foundations of infant emotional development.
Decoding Time's Toll: Revolutionary Brain Study Maps How Addiction Accelerates Aging at the Molecular Level
In a landmark study published in Genomic Psychiatry, researchers have uncovered compelling evidence that substance use disorders (SUDs) trigger accelerated biological aging in the brain, revealing distinct molecular signatures that vary by drug type. This groundbreaking research, which appears as a featured Research Article, offers the first comprehensive analysis using brain-specific epigenetic clocks to measure aging in individuals with alcohol, opioid, and stimulant use disorders.
Genomic Press Journals Now Indexed by Google Scholar
In the current ecosystem of scientific publishing, few events signal structural legitimacy more unequivocally than full indexing by Google Scholar, the most universally accessed academic search engine in the world. It is with great pride and deliberate emphasis that we announce: all three of Genomic Press’s flagship journals: Brain Medicine, Genomic Psychiatry, and Psychedelics, are now fully indexed, searchable, and integrated into the core infrastructure of digital scholarship.
A Drug to Forget: PTSD Memory Disruption Achieved with Single Dose in Female Mice
In a striking new study published in Brain Medicine (Genomic Press, New York), neuroscientists report that the drug Osanetant, when administered shortly after trauma, significantly reduced fear memory in a PTSD-like model in female mice. The peer-reviewed study offers an important preclinical step toward gender-specific interventions for post-traumatic stress disorder.
A Plastic Spoon in Your Brain: Pioneering Microplastics Brain Study Shows Alarming Results and Possible Elimination Pathways
In a groundbreaking paper published in Brain Medicine (Genomic Press, New York), researchers have presented comprehensive evidence about microplastic accumulation in human brain tissue, revealing concerning levels and potential health implications. This landmark study, which appears as a featured and peer-reviewed Commentary article, offers the first detailed analysis of these findings while exploring possible strategies for reducing exposure and enhancing elimination of these particles from the body.
Manic Symptoms: A Hidden Layer of Complexity in Schizophrenia Treatment
New research reveals that over a quarter of patients with schizophrenia spectrum disorders (SSDs) experience significant manic symptoms, suggesting a need to reevaluate current diagnostic and treatment approaches. The groundbreaking study, conducted by researchers at the Aristotle University of Thessaloniki, highlights the intricate relationship between positive psychotic symptoms and manic features in schizophrenia.
From Children's Literature to Scientific Innovation: Genomic Press Finds Its Identity in Flicts
In a thought-provoking editorial published in Genomic Psychiatry (Genomic Press, New York), Editor-in-Chief Dr. Julio Licinio explores how a Brazilian children's book about a lonely color has become the philosophical foundation for one of science's most innovative contemporary publishing platforms...
Groundbreaking Research Links Air Pollution to Autism Risk in Inaugural Issue of Brain Medicine
In a landmark paper published in Brain Medicine (Genomic Press), researchers have presented compelling evidence linking air pollution exposure to increased autism spectrum disorder (ASD) risk, marking a significant milestone in our understanding of environmental factors in neurodevelopmental disorders...
Pioneering Psilocybin Treatment Study for Anorexia Shows Promise
In a groundbreaking paper published in Psychedelics (Genomic Press), researchers have presented the first clinical trial evaluating psilocybin treatment for anorexia nervosa, marking a significant milestone in eating disorder research...
Study on Psilocybin Therapy Eligibility Receives Unprecedented Global Media Coverage
In a landmark paper published in Psychedelics (Genomic Press), researchers have provided the first comprehensive analysis revealing that over 5 million Americans with depression could benefit from psilocybin-assisted therapy...
Brain Changes During Psilocybin Treatment for BDD: International Research Spotlight
In a groundbreaking paper published in Psychedelics (Genomic Press), researchers from Columbia University have provided the first evidence of how psilocybin alters brain connectivity in patients with body dysmorphic disorder (BDD)...
Early Multiple Sclerosis (MS) Indicators as Disability Predictors Draw Worldwide Recognition
In a groundbreaking paper published in Brain Medicine (Genomic Press), researchers have provided the first comprehensive analysis revealing how specific initial symptoms of multiple sclerosis (MS) can predict long-term disability outcomes...
Gene Discovery Reveals Missing Piece in Brain Development Puzzle
A decade-long study tracking three Colombian siblings has unveiled a groundbreaking genetic discovery that's catching the attention of neuroscientists worldwide...
